Clinical trial
Local Haemodynamic Effects of Apelin Agonists and Antagonists in Man in Vivo
NCT02150694 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Local Haemodynamic Effects of Apelin Agonists and Antagonists in Man in Vivo
- Lead sponsor
- University of Cambridge
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- August 31, 2013
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease